NCT04110821 Quality of Life After Conservative and Surgical Treatment of Pelvic Organ Prolapse
| NCT ID | NCT04110821 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Pelvic Organ Prolapse |
| Study Type | OBSERVATIONAL |
| Enrollment | 134 participants |
| Start Date | 2019-09-15 |
| Primary Completion | 2028-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 134 participants in total. It began in 2019-09-15 with a primary completion date of 2028-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an observational study that gives baseline and follow-up information, that does not directly influence the allocation of patients to various treatment Options (conservative and surgical therapy of Pelvic Organ Prolapse) but the knowledge gained of the data will help to develop treatment strategies.
Eligibility Criteria
Inclusion Criteria: \- Pelvic Organ Prolapse (POP) Exclusion Criteria: * \< 18 years * Patients unable to understand an informed consent * Patients unwilling to participate * emergency operations * pregnancy * Overactive Bladder without descensus * Stool incontinence without POP
Contact & Investigator
Daniel Steinemann, PD Dr. med.
PRINCIPAL INVESTIGATOR
University Hospital Basel, Clarunis
Frequently Asked Questions
Who can join the NCT04110821 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pelvic Organ Prolapse. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04110821 currently recruiting?
Yes, NCT04110821 is actively recruiting participants. Contact the research team at daniel.steinemann@clarunis.ch for enrollment information.
Where is the NCT04110821 trial being conducted?
This trial is being conducted at Basel, Switzerland.
Who is sponsoring the NCT04110821 clinical trial?
NCT04110821 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Daniel Steinemann, PD Dr. med. at University Hospital Basel, Clarunis. The trial plans to enroll 134 participants.